This study aimed to assess the effectiveness, safety, and feasibility of a novel robotic surgical system—the KangDuo Surgical Robot-01 (KD-SR-01)—for treating clinical stage I–III distal gastric cancer (GC) by comparing it to conventional laparoscopic gastrectomy (LG).
Methods:
From September to December 2023, 15 patients with distal GC underwent gastrectomies using the KD-SR-01 (KD group). An additional 15 cases of LG performed by the same surgeon during the same period were selected as the control group (LG group). Preoperative, intraoperative, and postoperative data were analyzed and compared between the two groups.
Results:
Both groups achieved the same surgical success rate, with no conversions to open surgery. The KD group exhibited significantly less blood loss (30 [20–60] mL versus 50 [30–200] mL, P < .001) and reported a lighter workload (27.5 ± 3.0 versus 30.1 ± 2.6, P = .011) compared to the LG group. Although the operation time in the KD group was significantly longer (213.3 ± 30.1 minutes versus 166.0 ± 32.8 minutes, P < .001), it was not significantly different from the LG group when excluding the device docking time of KD-SR-01 (179.7 ± 24.5 minutes versus 166.0 ± 32.8 minutes, P = .207). There were no significant differences in postoperative hospital stay (7.7 ± 1.5 days versus 7.3 ± .8 days, P = .357) and complication rates (26.7% versus 40.0%, P = .700) between the two groups.
Conclusion:
The KD-SR-01 is safe and effective for treating distal GC and may be a viable alternative to conventional LG.
SungH, FerlayJ, SiegelRL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021; 71(3):209–249.
2.
HyungWJ, YangHK, ParkYK, et al.; Korean Laparoendoscopic Gastrointestinal Surgery Study Group. Long-Term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: The KLASS-02-RCT randomized clinical trial. J Clin Oncol, 2020; 38(28):3304–3313.
3.
YuJ, HuangC, SunY, et al.; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-open-access survival in patients with locally advanced gastric cancer: The CLASS-01 randomized clinical trial. JAMA, 2019; 321(20):1983–1992.
4.
HuY, HuangC, SunY, et al.Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: A randomized controlled trial. J Clin Oncol, 2016; 34(12):1350–1357.
5.
RodriguesSP, HoremanT, BlomjousMS, et al.Laparoscopic suturing learning curve in an open versus closed box trainer. Surg Endosc, 2016; 30(1):315–322.
6.
SudaK, NakauchiM, InabaK, et al.Robotic surgery for upper gastrointestinal cancer: Current status and future perspectives. Dig Endosc, 2016; 28(7):701–713.
KimHH, HanSU, KimMC, et al.; Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: The KLASS-01 randomized clinical trial. JAMA Oncol, 2019; 5(4):506–513.
9.
KimW, KimHH, HanSU, et al.; Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: Short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg, 2016; 263(1):28–35.
10.
WooY, HyungWJ, PakKH, et al.Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg, 2011; 146(9):1086–1092.
11.
SibioS, La RovereF, Di CarloS. Benefits of minimally invasive surgery in the treatment of gastric cancer. World J Gastroenterol, 2022; 28(30):4227–4230.
12.
OjimaT, NakamuraM, NakamoriM, et al.Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: Study protocol for a randomized controlled trial. Trials, 2018; 19(1):409.
13.
SongJ, OhSJ, KangWH, et al.Robot-assisted gastrectomy with lymph node dissection for gastric cancer: Lessons learned from an initial 100 consecutive procedures. Ann Surg, 2009; 249(6):927–932.
14.
PatritiA, CeccarelliG, BellochiR, et al.Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma. Surg Endosc, 2008; 22(12):2753–2760.
15.
BolenzC, GuptaA, HotzeT, et al.Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol, 2010; 57(3):453–458.
16.
LimJH, LeeWJ, ChoiSH, et al.Cholecystectomy using the Revo-i robotic surgical system from Korea: The first clinical study. Updates Surg, 2021; 73(3):1029–1035.
17.
SamalaviciusNE, JanusonisV, SiaulysR, et al.Robotic surgery using Senhance(®) robotic platform: Single center experience with first 100 cases. J Robot Surg, 2020; 14(2):371–376.
18.
FanS, HaoH, ChenS, et al.Robot-Assisted laparoscopic radical prostatectomy using the KangDuo surgical robot system vs the da Vinci Si robotic system. J Endourol, 2023; 37(5):568–574.
19.
LiuY, WangY, WangC, et al.Comparison of short-term outcomes of robotic-assisted radical colon cancer surgery using the Kangduo Surgical Robotic System and the Da Vinci Si robotic system: A prospective cohort study. Int J Surg, 2024; 110(3):1511–1518.
20.
SunZ, MaT, HuangZ, et al.Robot-assisted radical resection of colorectal cancer using the KangDuo surgical robot versus the da Vinci Xi robotic system: Short-term outcomes of a multicentre randomised controlled noninferiority trial. Surg Endosc, 2024; 38(4):1867–1876.
21.
WangFH, ZhangXT, TangL, et al.The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2024, 2023; 44(1):127–172.
22.
LundS, YanM, D’AngeloJ, et al.NASA-TLX assessment of workload in resident physicians and faculty surgeons covering trauma, surgical intensive care unit, and emergency general surgery services. Am J Surg, 2021; 222(6):1158–1162.
23.
DegiuliM, ReddavidR, TomatisM, et al.; of the Italian Gastric Cancer Study Group (IGCSG). D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian gastric cancer study group D1 versus D2 randomised controlled trial. Eur J Cancer, 2021; 150:10–22.
24.
LuJ, ZhengCH, XuBB, et al.Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial. Ann Surg, 2021; 273(5):858–867.
25.
ParkSH, HyungWJ. Current perspectives on the safety and efficacy of robot-assisted surgery for gastric cancer. Expert Rev Gastroenterol Hepatol, 2020; 14(12):1181–1186.
26.
OmoriT, YamamotoK, HaraH, et al.Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: A propensity score-matched analysis. Surg Endosc, 2022; 36(8):6223–6234.
27.
ChenL, WangQ, LiuY, et al.A meta-analysis of robotic gastrectomy versus open gastrectomy in gastric cancer treatment. Asian J Surg, 2022; 45(2):698–706.
28.
ShibasakiS, SudaK, NakauchiM, et al.Non-robotic minimally invasive gastrectomy as an independent risk factor for postoperative intra-abdominal infectious complications: A single-center, retrospective and propensity score-matched analysis. World J Gastroenterol, 2020; 26(11):1172–1184.
29.
ParkJY, JoMJ, NamBH, et al.Surgical stress after robot-assisted distal gastrectomy and its economic implications. Br J Surg, 2012; 99(11):1554–1561.
30.
HyunMH, LeeCH, KwonYJ, et al.Robot versus laparoscopic gastrectomy for cancer by an experienced surgeon: Comparisons of surgery, complications, and surgical stress. Ann Surg Oncol, 2013; 20(4):1258–1265.
31.
PanHF, WangG, LiuJ, et al.Robotic versus laparoscopic gastrectomy for locally advanced gastric cancer. Surg Laparosc Endosc Percutan Tech, 2017; 27(6):428–433.
32.
BoboZ, XinW, JiangL, et al.Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: Meta-analysis and trial sequential analysis of prospective observational studies. Surg Endosc, 2019; 33(4):1033–1048.
33.
LiZ, LiJ, LiB, et al.Robotic versus laparoscopic gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched analysis. Cancer Manag Res, 2018; 10:705–714.
34.
ChenK, PanY, ZhangB, et al.Robotic versus laparoscopic gastrectomy for gastric cancer: A systematic review and updated meta-analysis. BMC Surg, 2017; 17(1):93.
35.
ParkJM, KimHI, HanSU, et al.Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy. Eur J Surg Oncol, 2016; 42(12):1944–1949.
36.
KandaM, KobayashiD, TanakaC, et al.Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer, 2016; 19(1):255–263.
37.
MisawaK, KurokawaY, MizusawaJ, et al.; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: Exploratory analysis of the JCOG1001 phase III trial. Gastric Cancer, 2022; 25(2):459–467.
38.
AritaT, IchikawaD, KonishiH, et al.Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg Oncol, 2015; 22(3):758–764.
39.
BrunsCJ, SchäferH, WolfgartenB, et al.Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract. Langenbecks Arch Chir Suppl Kongressbd, 1996; 113:146–149.
40.
ItoY, KandaM, ItoS, et al.Intraoperative blood loss is associated with shortened postoperative survival of patients with stage II/III gastric cancer: Analysis of a multi-institutional dataset. World J Surg, 2019; 43(3):870–877.
41.
LiangYX, GuoHH, DengJY, et al.Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol, 2013; 19(33):5542–5550.
42.
MikiC, HiroJ, OjimaE, et al.Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol), 2006; 18(1):60–66.
43.
HuangKH, LanYT, FangWL, et al.Comparison of the operative outcomes and learning curves between laparoscopic and robotic gastrectomy for gastric cancer. PLoS One, 2014; 9(10):e111499.
44.
WangY, ZhaoX, SongY, et al.A systematic review and meta-analysis of robot-assisted versus laparoscopically assisted gastrectomy for gastric cancer. Medicine (Baltimore), 2017; 96(48):e8797.
45.
LiuHB, WangWJ, LiHT, et al.Robotic versus conventional laparoscopic gastrectomy for gastric cancer: A retrospective cohort study. Int J Surg, 2018; 55:15–23.
46.
FanS, DaiX, YangK, et al.Robot-assisted pyeloplasty using a new robotic system, the KangDuo-Surgical Robot-01: A prospective, single-centre, single-arm clinical study. BJU Int, 2021; 128(2):162–165.
47.
RassweilerJJ, AutorinoR, KleinJ, et al.Future of robotic surgery in urology. BJU Int, 2017; 120(6):822–841.
48.
RongL, GuodongZ, YuningS, et al.Animal experiment for 5G remote robotic surgery. Chin J Laparosc Surg, 2019; 12:45–48.
